Diana F. Clarke, Pharm.D.
Assistant Professor
Boston University School of Medicine
Dept of Pediatrics
Infectious Diseases

PharmD, State University of New York at Buffalo



Diana Clarke, PhD is an Assistant Professor of Pediatrics in Infectious Diseases at the Boston University School of Medicine. She originally earned a doctorate of pharmacy and worked as an assistant professor as well as a clinical pharmacist before adjuncting as an instructor of pediatrics at the Boston University School of Medicine for one year. After 26 years of working in the industry, she was hired as an Assistant Professor at BUSM, but still continues to work as a research pharmacist at BMC. Her commitment to pediatrics is demonstrated through her 12 year membership to the WHO Pediatric Antiretroviral Working Group and her past experience as the Vice Chair of the Pharmacy Resource Committee in the International Maternal Pediatric-Adolescent AIDS Clinical Trials Network Group.



P1097A - TO# LDR 04 MOD 02 - Raltegravir Pharmacokinetics and Safety in Neonates
01/01/2014 - 12/31/2019 (PI)
Johns Hopkins University NIH-NIAID

P1097A – TO# LDR 04 MOD 03 – Raltegravir Pharmacokinetics and Safety in Neon…..
01/01/2014 - 12/31/2019 (PI)
Johns Hopkins University Merck

P1110 - TO# LDR 02 MOD 03 - Phase I Trial (Merck)
01/01/2014 - 12/31/2019 (PI)
Johns Hopkins University NIH-NIAID

LOC-IMPAACT Leadership Group - JHU P1097 and P1110
01/01/2014 - 11/30/2015 (PI)
Johns Hopkins University NIH-NIAID
5 UM1 AI068632-09

IMPAACT Leadership Award: Chair, Protocol P1097
06/01/2012 - 12/31/2013 (PI)
Johns Hopkins University NIH-NIAID

IMPAACT Leadership: Vice Chair Pharmacy Resource Committee
06/01/2012 - 12/31/2013 (PI)
Johns Hopkins University NIH-NIAID

IMPAACT Leadership: International Maternal Pediatric Adolescent AIDS Clinical Trials Group
06/01/2011 - 05/31/2012 (PI)
Social & Scientific Systems Inc. NIH-NIAID

IMPAACT Leadership - P1097 Protocol Chair
06/01/2011 - 05/31/2012 (PI)
Social & Scientific Systems Inc. NIH-NIAID

IMPAACT P1097
06/01/2010 - 05/31/2011 (PI)
Social & Scientific Systems Inc. NIH-NIAID



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Schreiner CN, Ahlfors CE, Wong RJ, Stevenson DK, Clarke DF, Mirochnick M. In Vitro Study on the Effect of Maraviroc or Dolutegravir on Bilirubin to Albumin Binding. Pediatr Infect Dis J. 2018 Sep; 37(9):908-909.View Related Profiles. PMID: 29561509.
     
  2. Clarke DF, Penazzato M, Capparelli E, Cressey TR, Siberry G, Sugandhi N, Mirochnick M. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations. Expert Rev Clin Pharmacol. 2018 Jan; 11(1):83-93.View Related Profiles. PMID: 29039686.
     
  3. Clarke DF, Yildirim I, Cooper ER. Rapid Initiation of Antiretrovirals in Two Newly Diagnosed HIV-infected Infants. Pediatr Infect Dis J. 2017 Jan; 36(1):61-62.View Related Profiles. PMID: 27749654.
     
  4. Clarke DF, Acosta EP, Rizk ML, Bryson YJ, Spector SA, Mofenson LM, Handelsman E, Teppler H, Welebob C, Persaud D, Cababasay MP, Wang J, Mirochnick M. Raltegravir pharmacokinetics in neonates following maternal dosing. J Acquir Immune Defic Syndr. 2014 Nov 1; 67(3):310-5.View Related Profiles. PMID: 25162819; PMCID: PMC4197108; DOI: 10.1097/QAI.0000000000000316;.
     
  5. Clarke DF, Wong RJ, Wenning L, Stevenson DK, Mirochnick M. Raltegravir in vitro effect on bilirubin binding. Pediatr Infect Dis J. 2013 Sep; 32(9):978-80.View Related Profiles. PMID: 23470680; PMCID: PMC3856729; DOI: 10.1097/INF.0b013e31829044a8;.
     
  6. Mirochnick M, Clarke D. Oseltamivir pharmacokinetics in pregnancy: a commentary. Am J Obstet Gynecol. 2011 Jun; 204(6 Suppl 1):S94-5.View Related Profiles. PMID: 21640232; DOI: 10.1016/j.ajog.2011.02.043;.
     
  7. Mirochnick M, Best BM, Clarke DF. Antiretroviral pharmacology: special issues regarding pregnant women and neonates. Clin Perinatol. 2010 Dec; 37(4):907-27, xi.View Related Profiles. PMID: 21078458; DOI: 10.1016/j.clp.2010.08.006;.
     
  8. Mirochnick M, Clarke DF, Dorenbaum A. Nevirapine: pharmacokinetic considerations in children and pregnant women. Clin Pharmacokinet. 2000 Oct; 39(4):281-93.View Related Profiles. PMID: 11069214.
     
  9. Mirochnick M, Clarke DF, McNamara ER, Cabral H. Bioequivalence of a propylene glycol-based liquid dapsone preparation and dapsone tablets. Am J Health Syst Pharm. 2000 Oct 1; 57(19):1775-7.View Related Profiles. PMID: 11030029.
     
  10. Mirochnick M, Michaels M, Clarke D, Breña A, Regan AM, Pelton S. Pharmacokinetics of dapsone in children. J Pediatr. 1993 May; 122(5 Pt 1):806-9.View Related Profiles. PMID: 8496767.
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 10 publications over 8 distinct years, with a maximum of 2 publications in 2000 and 2017

YearPublications
19931
20002
20101
20111
20131
20141
20172
20181
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map

617.638.5300
Download vCard

Clarke's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (55) concept(s)
_
Co-Authors
See all (5) people
_
Similar People
See all (60) people
_
Same Department
Search Department